SEARCH NEWS & VIEWS


Scripps Research Institute Names Peter Schultz as CEO, Steve Kay as President
TSRI and UC San Diego Launch New Consortium to Create 'Virtual Cell'
Institute Receives $5.65 Million Gift from Philanthropist Helen Dorris

NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT




FOLLOW US
1
Scripps Research Institute Names Peter Schultz as CEO, Steve Kay as President

"Their shared vision of creating a unique position for the Institute at the forefront of basic and translational research is tremendously exciting," says Dick Gephardt, Chair of the TSRI Board of Trustees and President/CEO of Gephardt Government Affairs.

TSRI and UC San Diego Launch New Consortium to Create 'Virtual Cell'

The new collaboration has a big mission: to map cells in space and time.

Institute Receives $5.65 Million Gift from Philanthropist Helen Dorris

The new gift will enhance the endowment for TSRI’s Dorris Neuroscience Center.

  • Institute Receives $12.5 Million Challenge Gift
  • Study by TSRI and Janssen Makes Major Advance Toward More Effective, Long-Lasting Flu Vaccine
  • Scientists Show How Aging Cripples the Immune System, Suggesting Benefits of Antioxidants
  • Team Finds a Better Way to Engineer Therapeutic Proteins into Antibodies
  • International Team Discovers the Ancient Origins of Deadly Lassa Virus
  • Team Makes Strides in Therapy Preventing Addiction Relapse by Erasing Drug-Associated Memories
  • Technology Meets Teamwork: Andrew Ward Unlocks Viruses’ Secrets
  • Team Finds New Antibody Weapons against Marburg Virus
  • Scientists Pinpoint Mechanism for Altered Pattern of Brain Growth in Autism Spectrum Disorder
  • TSRI-Designed Drug Candidate Significantly Reduces HIV Reactivation Rate
  • Chemists Find Efficient, Scalable Way to Synthesize Potential Brain-Protecting Compound
  • AIDS Vaccine Candidate Successfully ‘Primes’ Immune System
  • Scientists Identify a Potential New Treatment for Osteoporosis
  • New Close-Up View Reveals Key Part of Ebola Virus Life Cycle
  • Team Shows Antitumor Agent Can Be Activated by Natural Response to Cell Stress